Panagiotis Karagiannis
Dr. med.
Panagiotis Karagiannis
PhD
  • Assistant physician
Working area

Location

O24
Languages
German (Mother tongue)
English
Greek

Areas of expertise

Awards

Memberships

Publications

Zurück
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
Vor

Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment
Georgouli M, Herraiz C, Crosas-Molist E, Fanshawe B, Maiques O, Perdrix A, Pandya P, Rodriguez-Hernandez I, Ilieva K, Cantelli G, Karagiannis P, Mele S, Lam H, Josephs D, Matias-Guiu X, Marti R, Nestle F, Orgaz J, Malanchi I, Fruhwirth G, Karagiannis S, Sanz-Moreno V
CELL. 2019;176(4):757-774.e23.

Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells
Correa I, Ilieva K, Crescioli S, Lombardi S, Figini M, Cheung A, Spicer J, Tutt A, Nestle F, Karagiannis P, Lacy K, Karagiannis S
FRONT IMMUNOL. 2018;9:493.

An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE
Josephs D, Nakamura M, Bax H, Dodev T, Muirhead G, Saul L, Karagiannis P, Ilieva K, Crescioli S, Gazinska P, Woodman N, Lomardelli C, Kareemaghay S, Selkirk C, Lentfer H, Barton C, Canevari S, Figini M, Downes N, Dombrowicz D, Corrigan C, Nestle F, Jones P, Gould H, Blower P, Tsoka S, Spicer J, Karagiannis S
ALLERGY. 2018;73(12):2328-2341.

Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields
Ilieva K, Fazekas-Singer J, Achkova D, Dodev T, Mele S, Crescioli S, Bax H, Cheung A, Karagiannis P, Correa I, Figini M, Marlow R, Josephs D, Beavil A, Maher J, Spicer J, Jensen-Jarolim E, Tutt A, Karagiannis S
FRONT IMMUNOL. 2017;8:1112.

AllergoOncology - the impact of allergy in oncology: EAACI position paper
Jensen-Jarolim E, Bax H, Bianchini R, Capron M, Corrigan C, Castells M, Dombrowicz D, Daniels-Wells T, Fazekas J, Fiebiger E, Gatault S, Gould H, Janda J, Josephs D, Karagiannis P, Levi-Schaffer F, Meshcheryakova A, Mechtcheriakova D, Mekori Y, Mungenast F, Nigro E, Penichet M, Redegeld F, Saul L, Singer J, Spicer J, Siccardi A, Spillner E, Turner M, Untersmayr E, Vangelista L, Karagiannis S
ALLERGY. 2017;72(6):866-887.

Anti-folate receptor-α IgE but not IgG recruits macrophages to attack tumors via TNF-α/MCP-1 signaling
Josephs D, Bax H, Dodev T, Georgouli M, Nakamura M, Pellizzari G, Saul L, Karagiannis P, Cheung A, Herraiz C, Ilieva K, Correa I, Fittall M, Crescioli S, Gazinska P, Woodman N, Mele S, Chiaruttini G, Gilbert A, Koers A, Bracher M, Selkirk C, Lentfer H, Barton C, Lever E, Muirhead G, Tsoka S, Canevari S, Figini M, Montes A, Downes N, Dombrowicz D, Corrigan C, Beavil A, Nestle F, Jones P, Gould H, Sanz-Moreno V, Blower P, Spicer J, Karagiannis S
CANCER RES. 2017;77(5):1127-1141.

IgG4 Characteristics and Functions in Cancer Immunity
Crescioli S, Correa I, Karagiannis P, Davies A, Sutton B, Nestle F, Karagiannis S
CURR ALLERGY ASTHM R. 2016;16(1):7.

IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin
Saul L, Ilieva K, Bax H, Karagiannis P, Correa I, Rodriguez-Hernandez I, Josephs D, Tosi I, Egbuniwe I, Lombardi S, Crescioli S, Hobbs C, Villanova F, Cheung A, Geh J, Healy C, Harries M, Sanz-Moreno V, Fear D, Spicer J, Lacy K, Nestle F, Karagiannis S
SCI REP-UK. 2016;6:29736.

TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination
Cantelli G, Orgaz J, Rodriguez-Hernandez I, Karagiannis P, Maiques O, Matias-Guiu X, Nestle F, Marti R, Karagiannis S, Sanz-Moreno V
CURR BIOL. 2015;25(22):2899-914.

[18F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodents
Haeusler D, Kuntner C, Nics L, Savli M, Zeilinger M, Wanek T, Karagiannis P, Lanzenberger R, Langer O, Shanab K, Spreitzer H, Wadsak W, Hacker M, Mitterhauser M
EUR J NUCL MED MOL I. 2015;42(5):741-9.

Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes
Jacquet L, Neueder A, Földes G, Karagiannis P, Hobbs C, Jolinon N, Mioulane M, Sakai T, Harding S, Ilic D
PLOS ONE. 2015;10(5):e0126860.

Alveolar rhabdomyosarcoma confined to the bone marrow with no identifiable primary tumour using FDG-PET/CT
Karagiannis P, Guth N, Thoennissen G, Bern C, Sperveslage J, Oschlies I, Bokemeyer C, Klapper W, Wardelmann E, Thoennissen N
Clin Sarcoma Res. 2015;5:24.

Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma
Karagiannis P, Villanova F, Josephs D, Correa I, Van Hemelrijck M, Hobbs C, Saul L, Egbuniwe I, Tosi I, Ilieva K, Kent E, Calonje E, Harries M, Fentiman I, Taylor-Papadimitriou J, Burchell J, Spicer J, Lacy K, Nestle F, Karagiannis S
ONCOIMMUNOLOGY. 2015;4(11):e1032492.

Effects of BRAF mutations and BRAF inhibition on immune responses to melanoma
Ilieva K, Correa I, Josephs D, Karagiannis P, Egbuniwe I, Cafferkey M, Spicer J, Harries M, Nestle F, Lacy K, Karagiannis S
MOL CANCER THER. 2014;13(12):2769-83.

Evaluating biomarkers in melanoma
Karagiannis P, Fittall M, Karagiannis S
Front Oncol. 2014;4:383.

Letzte Aktualisierung aus dem FIS: 18.08.2019 - 05:18 Uhr